Estradiol Completed Phase 2 Trials for Malignancies / Prostate Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00167648Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer